Skip to content

Effect of Zanthoxylum Nitidum Tincture for Paronychia Caused by Afatinib

A Clinical Study on the Treatment of Paronychia Caused by Afatinib With Zanthoxylum Nitidum Tincture

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03908892
Enrollment
110
Registered
2019-04-09
Start date
2019-06-12
Completion date
2022-12-31
Last updated
2022-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paronychia

Keywords

Paronychia, Zanthoxylum nitidum tincture, Afatinib

Brief summary

This is a randomized control trial evaluating the efficacy of zanthoxylum nitidum tincture on preventing progression of paronychia caused by afatinib from grade 1 to grade 2/3. Enrolled participates will randomly receive original treatment or original treatment plus zanthoxylum nitidum tincture immersion of the sick nail(s).

Interventions

DRUGzanthoxylum nitidum tincture

Local application with zanthoxylum nitidum tincture soaked blocks for the sick nail(s) for 30 minutes, twice a day.

Local use of 1% tetracycline ointment for the sick nail(s), 3 times a day

Sponsors

Guangzhou University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Pathologically or cytologically confirmed non-small cell lung cancer; 2. Undergoing treatment with afatinib; 3. With grade 1 paronychia; 4. Age between 18 to 80 years old; 5. Estimated life expectancy of more than months; 6. With the written informed consent.

Exclusion criteria

1. Paronychia before afatinib treatment; 2. Grade 2 or severer paronychia; 3. Stop using afatinib or with reduced dose of afatinib; 4. Currently diagnosed with severe encephalopathy or psychiatric disorders affecting patients ability of self expression. 5. Has other legal, medical or ethical reasons that patients are not appropriate for clinical study.

Design outcomes

Primary

MeasureTime frameDescription
Paronychia progress rateThrough study completion, an average of 10 days.Incidence of grade 2 or more paronychia during paronychia treatment period will be reported. This period will be from randomization till paronychia relief or progression. Frequency of evaluation for paronychia will be everyday.

Secondary

MeasureTime frameDescription
Time to paronychia progressThrough study completion, an average of 10 days.The time elapsed from randomization to either the date of grade 2 or more paronychia occurrence, treatment completion, or last follow-up information. Frequency of evaluation for paronychia will be everyday.
Time to paronychia reliefThrough study completion, an average of 10 days.The time elapsed from randomization to either the date of paronychia relief, treatment completion, or last follow-up information. Paronychia relief is defined as that paronychia disappears. Frequency of evaluation for paronychia will be everyday.

Countries

China

Contacts

Primary ContactYanjuan Zhu, Dr
zyjsophy@gzucm.edu.cn86 20 81887233
Backup ContactYihong Liu, Dr
yihongl@gzucm.edu.cn80 20 81887233

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026